BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10471528)

  • 1. Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis.
    Leoncini L; Cossu A; Megha T; Bellan C; Lazzi S; Luzi P; Tosi P; Barbini P; Cevenini G; Pileri S; Giordano A; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 1999 Oct; 83(2):203-9. PubMed ID: 10471528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
    Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
    Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1.
    Leoncini L; Megha T; Lazzi S; Bellan C; Luzi P; Tosi P; Cevenini G; Barbini P; Ascani S; Briskomatis A; Pileri S; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 1998 Jul; 77(3):408-14. PubMed ID: 9663604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications.
    Jin YH; Park CK
    J Korean Med Sci; 2002 Jun; 17(3):322-7. PubMed ID: 12068134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity.
    Leoncini L; Lazzi S; Scano D; Mura A; Onida A; Massarelli G; Tosi P; Barbini P; Cevenini G; Massai MR; Pileri S; Falini B; Giordano A; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 2000 Jun; 86(6):777-81. PubMed ID: 10842190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
    Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
    Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody.
    Weiss LM; Strickler JG; Medeiros LJ; Gerdes J; Stein H; Warnke RA
    Hum Pathol; 1987 Nov; 18(11):1155-9. PubMed ID: 3679189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
    Kudoh S; Kumaravel TS; Kuramavel B; Eguchi M; Asaoku H; Dohy H; Fujiwara M; Sasaki N; Tanaka K; Kamada N
    Jpn J Cancer Res; 1999 Nov; 90(11):1262-9. PubMed ID: 10622539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
    Zukerberg LR; Yang WI; Arnold A; Harris NL
    Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.
    Leoncini L; Bellan C; Cossu A; Claudio PP; Lazzi S; Cinti C; Cevenini G; Megha T; Laurini L; Luzi P; Orcioni GF; Piccioli M; Pileri S; Giardino C; Tosi P; Giordano A
    Clin Cancer Res; 1999 Dec; 5(12):4065-72. PubMed ID: 10632341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation.
    Ito Y; Yoshida H; Nakano K; Takamura Y; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
    Pathol Res Pract; 2002; 198(6):397-402. PubMed ID: 12166896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of meiotic competence in mouse oocytes: absolute amounts of p34(cdc2), cyclin B1, cdc25C, and wee1 in meiotically incompetent and competent oocytes.
    Kanatsu-Shinohara M; Schultz RM; Kopf GS
    Biol Reprod; 2000 Dec; 63(6):1610-6. PubMed ID: 11090427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth patterns of diffuse non-Hodgkin's lymphomas estimated from mitotic and apoptotic indices.
    Spina D; Leoncini L; Megha T; Gallorini M; Tosi P; Pileri S; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 1997 Oct; 73(2):178-83. PubMed ID: 9335438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
    Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas.
    Bai M; Tsanou E; Agnantis NJ; Chaidos A; Dimou D; Skyrlas A; Dimou S; Vlychou M; Galani V; Kanavaros P
    Histol Histopathol; 2003 Apr; 18(2):449-57. PubMed ID: 12647795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.